Literature DB >> 21961099

Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline.

R H Hunt, S D Xiao, F Megraud, R Leon-Barua, F Bazzoli, S van der Merwe, L G Vaz Coelho, M Fock, S Fedail, H Cohen, P Malfertheiner, N Vakil, S Hamid, K L Goh, B C Y Wong, J Krabshuis, A Le Mair.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21961099

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN： 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  135 in total

1.  Association between dietary carbohydrate intake, glycemic index and glycemic load, and risk of gastric cancer.

Authors:  Yao Ye; Yihua Wu; Jinming Xu; Kefeng Ding; Xiaoyun Shan; Dajing Xia
Journal:  Eur J Nutr       Date:  2016-02-12       Impact factor: 5.614

2.  Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.

Authors:  Amin Talebi Bezmin Abadi
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

3.  Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori.

Authors:  Rebecca Smiley; James Bailey; Mahadevan Sethuraman; Norberto Posecion; M Showkat Ali
Journal:  J Microbiol       Date:  2013-10-31       Impact factor: 3.422

4.  N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.

Authors:  Luís Eduardo S Fontes; Ana Luiza C Martimbianco; Carolina Zanin; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

Review 5.  Vaccines against enteric infections for the developing world.

Authors:  Cecil Czerkinsky; Jan Holmgren
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

6.  A link between cold environment and cancer.

Authors:  Ankit Sharma; Harphool Kumar Verma; Savitri Joshi; Mahaveer Singh Panwar; Chandi C Mandal
Journal:  Tumour Biol       Date:  2015-03-04

7.  Vonoprazan-Based Helicobacter pylori Eradication Therapy: Time to Get Kompetitive?

Authors:  Eun Hye Kim; Chan Hyuk Park
Journal:  Dig Dis Sci       Date:  2017-11       Impact factor: 3.199

8.  Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease.

Authors:  Mohammad Javad Ehsani Ardakani; Mohammad Aghajanian; Amir Ahmad Nasiri; Hamid Mohaghegh-Shalmani; Homayoun Zojaji; Iradj Maleki
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

Review 9.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

10.  Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.

Authors:  Fan Hongying; Wu Xianbo; Yu Fang; Bai Yang; Long Beiguo
Journal:  Clin Vaccine Immunol       Date:  2013-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.